Malignant peritoneal mesothelioma interactome with 417 novel protein-protein interactions

  • 0Supercomputer Education and Research Centre, Indian Institute of Science, Bengaluru, 560012, India. kalyanithepebble@gmail.com.

|

|

Summary

This summary is machine-generated.

We built a protein interaction map for malignant peritoneal mesothelioma (MPeM) to identify potential drug targets. This interactome analysis revealed key biological pathways and identified 39 repurposable drugs for MPeM treatment.

Area Of Science

  • Oncology
  • Bioinformatics
  • Genomics

Background

  • Malignant peritoneal mesothelioma (MPeM) is a rare and aggressive cancer with poor prognosis.
  • Current treatment options are limited, highlighting the need for novel therapeutic strategies.

Purpose Of The Study

  • To construct and analyze the protein-protein interaction (PPI) network of MPeM-associated genes.
  • To identify potential drug targets and repurposable drugs for MPeM treatment.
  • To uncover molecular pathways and biological associations relevant to MPeM.

Main Methods

  • Construction of the MPeM protein interactome using known and computationally predicted PPIs (HiPPIP model).
  • Analysis of the interactome for transcriptomic associations, functional modules, and drug repurposing potential.
  • Validation of interactome genes and novel interactors using transcriptomic data.

Main Results

  • The MPeM interactome comprised over 400 novel and 4700 known PPIs, with significant transcriptomic validation.
  • Identification of 39 potentially repurposable drugs, 29 with existing preclinical or clinical evidence for mesothelioma or related cancers.
  • Discovery of functional modules linked to chromosomal segregation, transcriptional dysregulation, IL-6 production, and hematopoiesis.
  • Significant overlap between MPeM and malignant pleural mesothelioma interactomes, indicating shared pathways.

Conclusions

  • The developed interactome is a valuable tool for understanding MPeM biology.
  • This approach successfully identified clinically translatable therapeutic opportunities for MPeM.

Related Concept Videos

Protein-protein Interfaces 02:04

12.5K

Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...

Protein Networks 02:26

3.9K

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...

mTOR Signaling and Cancer Progression 03:03

3.7K

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

The Tumor Microenvironment 02:17

6.6K

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

Interactions Between Signaling Pathways 01:19

6.2K

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

Abnormal Proliferation 02:23

4.5K

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...